Pulmonary FibrosisSymptoms, Doctors, Treatments, Advances & More
Learn About Pulmonary Fibrosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Taubman Center
Director of the Michigan Medicine Interstitial Lung Disease program, Vice-Chair of the Medical School Institutional Review Board for Human Subjects Research, Associate Program Director Internal Medicine Residency Program - Research, Co-Director University of Michigan Medical School Scientific Discovery Pathway, Steering committee chair for the pulmonary fibrosis foundations Care Center Network and Patient Registry. Dr. Flaherty is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Flaherty is board certified in Pulmonary Disease.
Baylor College Of Medicine - Pulmonary
Ivan Rosas, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Ivan Rosas specializes in Pulmonary Disease and works at BCM - Faculty Group Practice. To make an appointment, please call (713) 798-2400. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Rosas is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Rosas is currently accepting new patients.
Temple University Hospital
Gerard Criner is an Intensive Care Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Criner is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Lung Transplant, and Embolectomy.
Summary: MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled study of nintedanib inhalation powder (MNKD-201) in patients with Idiopathic Pulmonary Fibrosis (IPF). The trial consists of Multiple Ascending Doses (MAD) with the primary objective to evaluate safety, tolerability and pharmacokinetics (PK) of MNKD-201 compared to placebo in patients with IPF.
Background: DNA is a structure in the body. It contains data about how the body develops and works. Telomeres are found on the end of chromosomes in DNA. Some people with short telomeres or other gene changes can develop diseases of the bone marrow, lung, and liver. Researchers want to see if low doses of the hormone drug danazol can help.